Your browser doesn't support javascript.
loading
Everything old is new again. revisiting hypophysectomy for the treatment of refractory cancer-related pain: a systematic review.
Almeida, Timoteo; Monaco, Bernardo A; Vasconcelos, Fernando; Piedade, Guilherme S; Morell, Alexis; Ogobuiro, Ifeanyichukwu; Lepski, Guilherme A; Furlanetti, Luciano L; Cordeiro, Karina K; Benjamin, Carolina; Jagid, Jonathan R; Cordeiro, Joacir G.
Afiliação
  • Almeida T; Department of Radiation Oncology, University of Miami, Miami, USA. txa631@miami.edu.
  • Monaco BA; Department of Neurosurgery, University of Miami, Miami, USA. txa631@miami.edu.
  • Vasconcelos F; Graduate Program in Principles of Surgery, Mackenzie Evangelical University, Paraná, Brazil. txa631@miami.edu.
  • Piedade GS; Graduate Program in Principles of Surgery, Mackenzie Evangelical University, Paraná, Brazil.
  • Morell A; Department of Neurosurgery, McGovern Medical School at UT Health Houston, Houston, USA.
  • Ogobuiro I; Graduate Program in Principles of Surgery, Mackenzie Evangelical University, Paraná, Brazil.
  • Lepski GA; Graduate Program in Principles of Surgery, Mackenzie Evangelical University, Paraná, Brazil.
  • Furlanetti LL; Department of Radiation Oncology, University of Miami, Miami, USA.
  • Cordeiro KK; Department of Neurosurgery, University of Sao Paulo, Sao Paulo, Brazil.
  • Benjamin C; Department of Neurosurgery, University of Sao Paulo, Sao Paulo, Brazil.
  • Jagid JR; Department of Anesthesiology, University of Miami, Miami, USA.
  • Cordeiro JG; Graduate Program in Principles of Surgery, Mackenzie Evangelical University, Paraná, Brazil.
Neurosurg Rev ; 47(1): 111, 2024 Mar 12.
Article em En | MEDLINE | ID: mdl-38467866
ABSTRACT
Cancer-related pain is a common and debilitating condition that can significantly affect the quality of life of patients. Opioids, NSAIDs, and antidepressants are among the first-line therapies, but their efficacy is limited or their use can be restricted due to serious side effects. Neuromodulation and lesioning techniques have also proven to be a valuable instrument for managing refractory pain. For patients who have exhausted all standard treatment options, hypophysectomy may be an effective alternative treatment. We conducted a comprehensive systematic review of the available literature on PubMed and Scielo databases on using hypophysectomy to treat refractory cancer-related pain. Data extraction from included studies included study design, treatment model, number of treated patients, sex, age, Karnofsky Performance Status (KPS) score, primary cancer site, lead time from diagnosis to treatment, alcohol injection volume, treatment data, and clinical outcomes. Statistical analysis was reported using counts (N, %) and means (range). The study included data from 735 patients from 24 papers treated with hypophysectomy for refractory cancer-related pain. 329 cancer-related pain patients were treated with NALP, 216 with TSS, 66 with RF, 55 with Y90 brachytherapy, 51 with Gamma Knife radiosurgery (GK), and 18 with cryoablation. The median age was 58.5 years. The average follow-up time was 8.97 months. Good pain relief was observed in 557 out of 735 patients, with complete pain relief in 108 out of 268 patients. Pain improvement onset was observed 24 h after TSS, a few days after NALP or cryoablation, and a few days to 4 weeks after GK. Complications varied among treatment modalities, with diabetes insipidus (DI) being the most common complication. Although mostly forgotten in modern neurosurgical practice, hypophysectomy is an attractive option for treating refractory cancer-related pain after failure of traditional therapies. Radiosurgery is a promising treatment modality due to its high success rate and reduced risk of complications.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dor do Câncer / Hipofisectomia Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dor do Câncer / Hipofisectomia Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article